Literature DB >> 31533041

A PRMT5-RNF168-SMURF2 Axis Controls H2AX Proteostasis.

Changzheng Du1, Landon J Hansen2, Simranjit X Singh3, Feiyifan Wang4, Ran Sun5, Casey J Moure6, Kristen Roso6, Paula K Greer6, Hai Yan6, Yiping He7.   

Abstract

H2AX safeguards genomic stability in a dose-dependent manner; however, mechanisms governing its proteostasis are poorly understood. Here, we identify a PRMT5-RNF168-SMURF2 cascade that regulates H2AX proteostasis. We show that PRMT5 sustains the expression of RNF168, an E3 ubiquitin ligase essential for DNA damage response (DDR). Suppression of PRMT5 occurs in methylthioadenosine phosphorylase (MTAP)-deficient glioblastoma cells and attenuates the expression of RNF168, leading to destabilization of H2AX by E3 ubiquitin ligase SMURF2. RNF168 and SMURF2 serve as a stabilizer and destabilizer of H2AX, respectively, via their dynamic interactions with H2AX. In supporting an important role of this signaling cascade in regulating H2AX, MTAP-deficient glioblastoma cells display higher levels of DNA damage spontaneously or in response to genotoxic agents. These findings reveal a regulatory mechanism of H2AX proteostasis and define a signaling cascade that is essential to DDR and that is disrupted by the loss of a metabolic enzyme in tumor cells.
Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  H2AX; MTAP; PRMT5; RNF168; SMURF2; glioblastoma

Mesh:

Substances:

Year:  2019        PMID: 31533041      PMCID: PMC7204040          DOI: 10.1016/j.celrep.2019.08.031

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  75 in total

Review 1.  Non-traditional functions of ubiquitin and ubiquitin-binding proteins.

Authors:  Joshua D Schnell; Linda Hicke
Journal:  J Biol Chem       Date:  2003-07-14       Impact factor: 5.157

2.  RNF168 binds and amplifies ubiquitin conjugates on damaged chromosomes to allow accumulation of repair proteins.

Authors:  Carsten Doil; Niels Mailand; Simon Bekker-Jensen; Patrice Menard; Dorthe Helena Larsen; Rainer Pepperkok; Jan Ellenberg; Stephanie Panier; Daniel Durocher; Jiri Bartek; Jiri Lukas; Claudia Lukas
Journal:  Cell       Date:  2009-02-06       Impact factor: 41.582

3.  RNF168 promotes noncanonical K27 ubiquitination to signal DNA damage.

Authors:  Marco Gatti; Sabrina Pinato; Alessio Maiolica; Francesca Rocchio; Maria Giulia Prato; Ruedi Aebersold; Lorenza Penengo
Journal:  Cell Rep       Date:  2015-01-08       Impact factor: 9.423

4.  Growth and metastases of human lung cancer are inhibited in mouse xenografts by a transition state analogue of 5'-methylthioadenosine phosphorylase.

Authors:  Indranil Basu; Joseph Locker; Maria B Cassera; Thomas J Belbin; Emilio F Merino; Xinyuan Dong; Ivan Hemeon; Gary B Evans; Chandan Guha; Vern L Schramm
Journal:  J Biol Chem       Date:  2010-12-06       Impact factor: 5.157

5.  H2AX haploinsufficiency modifies genomic stability and tumor susceptibility.

Authors:  Arkady Celeste; Simone Difilippantonio; Michael J Difilippantonio; Oscar Fernandez-Capetillo; Duane R Pilch; Olga A Sedelnikova; Michael Eckhaus; Thomas Ried; William M Bonner; André Nussenzweig
Journal:  Cell       Date:  2003-08-08       Impact factor: 41.582

6.  Abnormal regulation of methylthioadenosine and polyamine metabolism in methylthioadenosine phosphorylase-deficient human leukemic cell lines.

Authors:  N Kamatani; D A Carson
Journal:  Cancer Res       Date:  1980-11       Impact factor: 12.701

7.  Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.

Authors:  Chien-Feng Li; Fu-Min Fang; Hsing-Jien Kung; Li-Tzong Chen; Jun-Wen Wang; Jen-Wei Tsai; Shih Chen Yu; Yu-Hui Wang; Shau-Hsuan Li; Hsuan-Ying Huang
Journal:  Oncotarget       Date:  2014-11-30

8.  A PALB2-interacting domain in RNF168 couples homologous recombination to DNA break-induced chromatin ubiquitylation.

Authors:  Martijn S Luijsterburg; Dimitris Typas; Marie-Christine Caron; Wouter W Wiegant; Diana van den Heuvel; Rick A Boonen; Anthony M Couturier; Leon H Mullenders; Jean-Yves Masson; Haico van Attikum
Journal:  Elife       Date:  2017-02-27       Impact factor: 8.140

9.  SWISS-MODEL: homology modelling of protein structures and complexes.

Authors:  Andrew Waterhouse; Martino Bertoni; Stefan Bienert; Gabriel Studer; Gerardo Tauriello; Rafal Gumienny; Florian T Heer; Tjaart A P de Beer; Christine Rempfer; Lorenza Bordoli; Rosalba Lepore; Torsten Schwede
Journal:  Nucleic Acids Res       Date:  2018-07-02       Impact factor: 16.971

10.  Chronic oxidative stress promotes H2AX protein degradation and enhances chemosensitivity in breast cancer patients.

Authors:  Tina Gruosso; Virginie Mieulet; Melissa Cardon; Brigitte Bourachot; Yann Kieffer; Flavien Devun; Thierry Dubois; Marie Dutreix; Anne Vincent-Salomon; Kyle Malcolm Miller; Fatima Mechta-Grigoriou
Journal:  EMBO Mol Med       Date:  2016-05-02       Impact factor: 12.137

View more
  10 in total

Review 1.  Protein arginine methylation: from enigmatic functions to therapeutic targeting.

Authors:  Qin Wu; Matthieu Schapira; Cheryl H Arrowsmith; Dalia Barsyte-Lovejoy
Journal:  Nat Rev Drug Discov       Date:  2021-03-19       Impact factor: 84.694

2.  The E3 ubiquitin ligase SMURF2 stabilizes RNA editase ADAR1p110 and promotes its adenosine-to-inosine (A-to-I) editing function.

Authors:  Praveen Koganti; Venkata Narasimha Kadali; Dhanoop Manikoth Ayyathan; Andrea Emanuelli; Biagio Paolini; Gal Levy-Cohen; Michael Blank
Journal:  Cell Mol Life Sci       Date:  2022-04-11       Impact factor: 9.261

Review 3.  Cellular pathways influenced by protein arginine methylation: Implications for cancer.

Authors:  Jian Xu; Stéphane Richard
Journal:  Mol Cell       Date:  2021-10-06       Impact factor: 17.970

Review 4.  The role of E3 ubiquitin ligases in the development and progression of glioblastoma.

Authors:  Luke M Humphreys; Paul Smith; Zhuoyao Chen; Shahd Fouad; Vincenzo D'Angiolella
Journal:  Cell Death Differ       Date:  2021-01-11       Impact factor: 12.067

Review 5.  Targeting the Ubiquitin System in Glioblastoma.

Authors:  Nico Scholz; Kathreena M Kurian; Florian A Siebzehnrubl; Julien D F Licchesi
Journal:  Front Oncol       Date:  2020-11-25       Impact factor: 6.244

6.  Effects of Sevoflurane Inhalation Anesthesia on the Intestinal Microbiome in Mice.

Authors:  Ci Han; Zhaodi Zhang; Nana Guo; Xueting Li; Mengyuan Yang; Yahui Peng; Xiaohui Ma; Kaijiang Yu; Changsong Wang
Journal:  Front Cell Infect Microbiol       Date:  2021-03-18       Impact factor: 5.293

7.  SMURF2 phosphorylation at Thr249 modifies glioma stemness and tumorigenicity by regulating TGF-β receptor stability.

Authors:  Manami Hiraiwa; Kazuya Fukasawa; Takashi Iezaki; Hemragul Sabit; Tetsuhiro Horie; Kazuya Tokumura; Sayuki Iwahashi; Misato Murata; Masaki Kobayashi; Akane Suzuki; Gyujin Park; Katsuyuki Kaneda; Tomoki Todo; Atsushi Hirao; Mitsutoshi Nakada; Eiichi Hinoi
Journal:  Commun Biol       Date:  2022-01-11

Review 8.  The regulatory roles of the E3 ubiquitin ligase NEDD4 family in DNA damage response.

Authors:  Xinxin Lu; Haiqi Xu; Jiaqi Xu; Saien Lu; Shilong You; Xinyue Huang; Naijin Zhang; Lijun Zhang
Journal:  Front Physiol       Date:  2022-08-26       Impact factor: 4.755

9.  Strategy for Development of Site-Specific Ubiquitin Antibodies.

Authors:  Ila van Kruijsbergen; Monique P C Mulder; Michael Uckelmann; Tibor van Welsem; John de Widt; Aldo Spanjaard; Heinz Jacobs; Farid El Oualid; Huib Ovaa; Fred van Leeuwen
Journal:  Front Chem       Date:  2020-02-21       Impact factor: 5.221

Review 10.  PRMT5 function and targeting in cancer.

Authors:  Hyungsoo Kim; Ze'ev A Ronai
Journal:  Cell Stress       Date:  2020-07-13
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.